Pedro Villablanca Spinetto, MD
Cardiovascular Disease · Detroit, MINPI 1518254630
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 71.3% of it on its own, with 25 other manufacturers making up the rest. Among cardiovascular disease clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 914 payments — averaging $678.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$442K
- Abiomed$81K
- Medtronic$37K
- Angiodynamics, Inc.$27K
- Teleflex LLC$19K
- Abbott$6K
- plus $9K from 20 others
Across 14 payments — averaging $15,993 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$129K
- Arrow International, Inc.$59K
- Essential Medical, Inc.$36K
What the payments were for
- Consulting fees$355,15557%
- Speaking & faculty fees$138,62822%
- Travel & lodging$97,88616%
- Food & beverage$28,6955%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 510 | $442,371 |
| Abiomed | 96 | $81,066 |
| Medtronic(2 entities) | 67 | $36,544 |
| Angiodynamics, Inc. | 43 | $26,568 |
| Teleflex LLC | 41 | $19,084 |
| Abbott | 61 | $5,766 |
| Arrow International, Inc. | 3 | $3,940 |
| Boston Scientific | 38 | $2,569 |
| Imperative Care, Inc | 13 | $310 |
| Bard Peripheral Vascular, Inc. | 3 | $266 |
| Biosense Webster, Inc. | 4 | $265 |
| Shockwave Medical, Inc | 1 | $249 |
| Amgen | 10 | $246 |
| Cardiovascular Systems Inc. | 2 | $192 |
| Philips North America LLC | 4 | $167 |
| Cook Medical LLC | 4 | $167 |
| W. L. Gore & Associates, Inc. | 1 | $145 |
| Livanova USA, Inc. | 1 | $144 |
| Procyrion, Inc. | 1 | $81 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $51 |
| Stryker | 2 | $37 |
| Opsens Inc. | 1 | $34 |
| Inari Medical, Inc. | 2 | $31 |
| Terumo Medical Corporation | 1 | $26 |
| Cardiva Medical, Inc. | 1 | $22 |
| Chiesi USA, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$361,146
- Impella$72,169
- COREVALVE EVOLUT R$29,887
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$28,693
- PASCAL$18,496
- MANTA$14,486
- AngioVac$14,020
- Edwards SAPIEN XT Transcatheter Heart Valve$12,550
- AlphaVac$11,744
- CoreValve Evolut$5,413
- MANTA Vascular Closure Device$3,609
- SAPIEN 3 Ultra RESILIA$2,591
- Mitra Clip system$1,398
- EVOQUE$824
- Watchman$817
- AMPLATZER Occluders$563
- AMPLATZER$450
- GUIDELINER$344
- GENERAL - STRUCTURAL HEART$324
- MitraClip$310
How this compares
$620,364 in reported general payments places this provider in the 95th percentile of 760 cardiovascular disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 48 | $51,537 |
| XareltoRivaroxaban | 14 | $11,596 |
| ClopidogrelClopidogrel Bisulfate | 33 | $907 |
| Metoprolol Succinate | 41 | $708 |
| Atorvastatin Calcium | 29 | $494 |
| Bumetanide | 12 | $469 |
| Losartan Potassium | 21 | $232 |
| Furosemide | 30 | $215 |
| Spironolactone | 21 | $195 |
| Rosuvastatin Calcium | 11 | $164 |
| Warfarin Sodium | 24 | $154 |
| Amlodipine Besylate | 25 | $126 |
| Potassium Chloride | 11 | $113 |
| Lisinopril | 12 | $105 |
| Omeprazole | 12 | $90 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Detroit
- Wayne WeaverDetroit$340K
- Brian OneillDetroit$250K
- Karthikeyan AnanthasubramaniamDetroit$112K
- Gerald KoenigDetroit$96K
- David LanfearDetroit$82K
- Celeste WilliamsDetroit$70K
- Mahir ElderDetroit$68K
- Cori RussellDetroit$67K
- Pedro Engel GonzalezDetroit$66K
- James LeeDetroit$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.